Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: Preliminary considerations

Journal of the European Academy of Dermatology and Venereology

Volumn 17, Issue 1, 2003, Pages 42-46

  Gangemi, S ^a   Merendino, R A ^a   Guarneri, F ^a   Minciullo, P L ^a   DiLorenzo, G ^b   Pacor, M ^c   Cannavo S P ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

CD30; ICAM 1; Interleukin 18; PASI; Psoriasis

Indexed keywords

CD30 ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNE SYSTEM; KERATINOCYTE; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PSORIASIS; TH1 CELL;

ADULT; ANTIGENS, CD30; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-18; MALE; PSORIASIS; SEVERITY OF ILLNESS INDEX;

EID: 0037259311     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2003.00647.x     Document Type: Article

References (28)

1. Elder JT, Nair RP, Henseler T et al. The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol 2001; 137(11): 1447-1454.
2. Hewett D, Samuelsson L, Polding J et al. Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single polymorphism map. Genomics 2002; 79(3): 305-314.
3. Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 2002; 46(1): 1-23, quiz 23-6.
4. Craven NM, Jackson CW, Kirby B et al. Cytokine gene polymorphisms in psoriasis. Br J Dermatol 2001; 144(4): 849-853.
5. Austin LM, Ozawa M, Kiluchi T, Walters IB, Krueger JG. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 1999; 113(5): 752-759.
6. Kashiwamura S, Okamura H. IL-18 and Il-18 receptor. Nippon Rinsho 1998; 56: 1798-1806.
7. Kohka H, Yoshino T, Iwagaki H et al. Interleukin-18/interferon gamma-inducing factor, a novel cytokin, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J Leukoc Biol 1998; 64: 519-527.
8. Dinarello CA. IL-18: a Th1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999; 103: 11-24.
9. Mee JB, Alam Y, Groves RW. Human keratinocytes constitutively produce but do not process interleukin-18. Br J Dermatol 2000; 143(2): 330-336.
10. Ohta Y, Hamada Y, Katsuoka K. Expression of IL-18 in psoriasis. Arch Dermatol Res 2001; 293(7): 334-342.
11. Del Prete GF, De Carli FM, Almerigogna F et al. Preferential expression of CD30 by human CD4+ T cells with Th2 phenotype. FASEB 1995; 9: 81-86.
12. D'Elios MM, Romagnani P, Scaletti C et al. In vivo CD30 expression in human disease with predominant activation of Th2-like T cells. J Leukoc Biol 1997; 61: 539-544.
13. Trepicchio WL, Ozawa M, Walters IB et al. Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions. J Clin Invest 1999; 104(11): 1527-1537.
14. Gottlieb AB, Grossman RM, Khandke L et al. Studies of the effect of cyclosporine in psoriasis in vivo: combined effects on activated T lymphocytes and epidermal regenerative maturation. J Invest Dermatol 1992; 98: 302-309.
15. Uyemura K, Yamamura M, Fivenson DM, Modlin RL, Nicholoff BJ. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T helper type 1 cell mediated response. J Invest Dermatol 1993; 101: 701-705.
16. Austin LM, Ozawa M, KiKuchi T, Walters IB, Krueger JG. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines in IFN-gamma, IL-2 and TNF-alpha, defining TC1 (CTL) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 1999; 113: 252-259.
17. Koga T, Duan H, Urabe K, Furue M. In situ localization of IFN-gamma-positive cells in psoriatic lesional epidermis. Eur J Dermatol 2002; 12(1): 20-23.
18. Yoo EK, Cassin M, Lessin SR, Rook AH. Complete molecular remission during biologic response modifier therapy for Sezary syndrome in associated with enhanced helper T type 1 cytokine production and natural killer cell activity. J Am Acad Dermatol 2001 August; 45(2): 208-216.
19. Rook AH, Gottlieb SL, Wolfe JT et al. Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis. Clin Exp Immunol 1997 January; 107(1): 16-20.
20. Zeoti DM, Figueiredo JF, Chiossi MP, Roselino AM. Serum cytokines in patients with Brazilian pemphigus foliaceus (fogo selvagem). Braz J Med Biol Res 2000 September; 33(9): 1065-1068.
21. Naik SM, Cannon G, Burbach GJ et al. Human keratinocytes constitutively express interleukin-18 secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene. J Invest Dermatol 1999; 113(5): 766-772.
22. Lamont AG, Adorini L. IL-12: a key cytokine in immune regulation. Immunol Today 1996; 17: 214-217.
23. Krasowska D, Chodorowska G, Koziol M, Czelej D. Plasma levels of sICAM-1 in patients affected by psoriasis: no relation to disease severity. Med Sci Monit 2000; 6(2): 353-355.
24. Griffiths CE, Boffa MJ, Gallatin WM, Martin S. Elevated levels of circulating intercellular adhesion molecule-3 (c-ICAM-3) in psoriasis. Acta Derm Venereol 1996; 76(1): 2-5.
25. De Pita O, Frezzolini A, Cianetti A et al. Squamous cell carcinoma-related antigen (SCCr-Ag), sICAM-1 and beta 2-microglobulin are useful markers of disease activity in psoriasis. Acta Derm Venereol 1999; 79(2): 132-135.
26. Schopf RE, Naumann S, Rehder M, Morsches B. Soluble intercellular adhesion molecule-1 levels in patients with psoriasis. Br J Dermatol 1993; 128(1): 34-37.
27. Urushihara N, Iwagaki H, Yagi T et al. Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia. J Pediatr Surg 2000; 35: 446-449.
28. Mondello MR, Califano L, Cannavò SP et al. Psoriasis and Cyclosporin: immunohistochemical aspects of the basement membrane. Acta Derm Venereol (Stockh) 1994; 186: 96-98.